Speedus EBIT Margin
The EBIT Margin (Operating Margin) of Speedus (SPDE) as of Jul 17, 2026 is -763.31 %.
Get this data via API
Financial Data API
EBIT Margin
-763.31 %
Last updated:
EBIT Margin (Operating Margin) of Speedus is 2026 -763.31 % . EBIT Margin (Operating Margin) of Speedus was 2025 - . It decreases by % lower compared to the previous year.
For Speedus, the operating (EBIT) margin of -763.3% is down versus -568.0% a few years ago.
Access this data via the Eulerpool API
Speedus Stock analysis
What does Speedus do? Speedus Corp is a US-American company that was founded in 1998 and has its headquarters in Philadelphia. The company specializes in medical services, including the delivery of medical samples, preparations, and instruments.
The company is divided into three divisions: Speedus, RTI, and Shamrock. Speedus offers courier services for the medical field, allowing customers to enter their requirements through an online platform or over the phone. This ensures that orders are processed quickly and reliably. The RTI division of Speedus specializes in clinical research and development. They offer consulting services that focus on accelerating clinical trials, improving protocols, and optimizing procedures of clinical research. The Shamrock division of Speedus, on the other hand, specializes in drug development. They offer services in the area of drug development, clinical trials, and drug approval.
Another important aspect of Speedus' business model is collaboration with partners and customers. For example, Speedus has agreed to collaborate with Quest Diagnostics, a leading company in the field of medical diagnostics. The agreement stipulates that Speedus will expand the Quest Diagnostic network by around 730 locations. This allows Quest customers nationwide to access their medical samples more quickly and efficiently.
In addition to medical sample delivery services, Speedus Corp also offers a wide range of products, including devices and accessories designed to support companies in conducting clinical trials. This includes specialized sample containers and packaging that ensure the safe transportation of samples and contribute to reliable and meaningful results in clinical trials.
In summary, Speedus Corp is an innovative and dynamic company that specializes in the field of medical services. With its wide range of services and products, the company is able to provide comprehensive support and advice to its customers, whether in the area of sample delivery, clinical trials, or drug development. Collaboration with partners and customers is a crucial part of Speedus Corp's success.
Output: Speedus Corp is a US-American company specializing in medical services, including the delivery of medical samples, preparations, and instruments. It is divided into three divisions: Speedus, RTI, and Shamrock. Speedus offers courier services for the medical field, while RTI focuses on clinical research and development, and Shamrock specializes in drug development. Speedus collaborates with partners like Quest Diagnostics to expand their network. They also offer a range of products and support services for clinical trials. Overall, Speedus Corp is an innovative and dynamic company focused on providing comprehensive medical services. Speedus is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Speedus stock
EBIT Margin (Operating Margin) of Speedus is -763.31 % in 2026.
Access this data via the Eulerpool API
Margins — Speedus
All Key Metrics — Speedus
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth